Hierarchies for data sources, reproduced from Cooper et al., 2005 [14].

<p>Hierarchies for data sources, reproduced from Cooper et al., 2005 [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0123853#pone.0123853.ref014" target="_blank">14</a>].</p

Percentage of BMGF-funded cost-per-DALY studies adhering to good practices for reporting health economic evaluations adapted from CHEERS statement [13] (n = 20).

<p>Percentage of BMGF-funded cost-per-DALY studies adhering to good practices for reporting health economic evaluations adapted from CHEERS statement [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0123853#pone.0123853.ref013" target="_blank">13</a>] (n = 20).</p

Number of identified economic evaluations by type of funder, country income level of setting where the economic evaluation was conducted, and area of interest.

<p>SR: systematic review; EE: economic evaluation; BMGF: Bill and Melinda Gates Foundation; DALY: Disability-Adjusted Life Year; TB: tuberculosis</p><p>Number of identified economic evaluations by type of funder, country income level of setting where the economic evaluation was conducted, and area of interest.</p

Flow of study selection.

<p>Flow of study selection.</p

Cost-effectiveness league chart showing ICERs of interventions being evaluated in identified BMGF-funded cost-per-DALY studies (n = 20).

<p>IPTi: Intermittent preventive treatment for infants, IPTp: Intermittent preventive treatment for pregnant women, LLTNs: Long-lasting treated nets, ITNs: Insecticide treated nets, IRS: Indoor residual spray, JE: Japanese encephalitis, HPV: Human papilloma virus, DOTS: Directly observed treatment, short course. Source of consumer price index and purchasing power parity: IMF World economic outlook database.</p

Most aggregated outcome reported in EEs published in LMICs, either funded by BMGF or not (n = 204).

<p>DALY: Disability-Adjusted Life Year; QALY: Quality-Adjusted Life Year; LY: life year.</p

Ranks of evidence used in the included BMGF-funded cost-per-DALY studies (n = 20).

<p>Full details of hierarchy of evidence were provided in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0123853#pone.0123853.t001" target="_blank">Table 1</a> [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0123853#pone.0123853.ref014" target="_blank">14</a>].</p